Stephen Klinger
Dermatology · New Orleans, LANPI 1356531677
Payments from drug & device makers
Across 611 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- AbbVie$2K
- Sanofi$1K
- E.r. Squibb & Sons, L.L.C.$613
- Novartis$554
- Regeneron Healthcare Solutions, Inc.$522
- plus $4K from 25 others
What the payments were for
- Consulting fees$1,65014%
- Food & beverage$9,27681%
- Education$4794%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 26 | $2,563 |
| AbbVie(2 entities) | 212 | $2,250 |
| Sanofi | 62 | $1,091 |
| E.r. Squibb & Sons, L.L.C. | 33 | $613 |
| Novartis | 45 | $554 |
| Regeneron Healthcare Solutions, Inc. | 24 | $522 |
| Pfizer | 29 | $505 |
| Amgen | 30 | $482 |
| UCB, Inc. | 19 | $354 |
| Sun Pharmaceutical Industries Inc. | 19 | $345 |
| Incyte Corporation | 13 | $279 |
| Galderma Laboratories, L.p. | 13 | $277 |
| LEO Pharma Inc. | 14 | $274 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 13 | $234 |
| Journey Medical Corporation | 12 | $214 |
| Lilly USA, LLC | 11 | $210 |
| Mayne Pharma Commercial LLC | 11 | $153 |
| Sanofi-aventis U.S. LLC | 2 | $123 |
| Almirall LLC | 4 | $66 |
| Mylan Pharmaceuticals Inc. | 3 | $41 |
| Aclaris Therapeutics, Inc. | 2 | $36 |
| Bristol Myers Squibb | 2 | $34 |
| Merz North America, Inc. | 2 | $30 |
| Organon | 3 | $28 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $21 |
| Nabriva Therapeutics, PLC | 1 | $20 |
| Dermira, Inc. | 1 | $20 |
| Merck | 1 | $18 |
| Mission Pharmacal Company | 1 | $16 |
| Cipher Pharmaceuticals US LLC | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$1,919
- Sotyktu$134
- EPIDUO FORTE$120
- DUPIXENT$117
How this compares
$11,405 in reported general payments places this provider in the 70th percentile of 189 dermatology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 52 | $199,576 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $116,468 |
| Humira(Cf) PenAdalimumab | 11 | $84,816 |
| Clobetasol Propionate | 109 | $3,546 |
| Tacrolimus | 14 | $2,043 |
| Ketoconazole | 127 | $1,606 |
| Triamcinolone Acetonide | 160 | $1,454 |
| Metronidazole | 25 | $997 |
| Fluconazole | 34 | $873 |
| Fluocinonide | 23 | $705 |
| Fluorouracil | 11 | $476 |
| Mupirocin | 54 | $417 |
| Clindamycin Phosphate | 20 | $337 |
| Ammonium Lactate | 31 | $324 |
| ValacyclovirValacyclovir Hcl | 17 | $308 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New Orleans
- Deirdre HooperNew Orleans$3.2M
- Sarah JacksonNew Orleans$1.7M
- Erin BohNew Orleans$945K
- William ClaiborneNew Orleans$384K
- Mara HaseltineNew Orleans$276K
- Julie MermilliodNew Orleans$222K
- Patricia HickhamNew Orleans$12K
- Jordan WhatleyBaton Rouge$27.9M
- Ira ThorlaBaton Rouge$5.6M
- Kyle ColemanThibodaux$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.